Vivos (RDGL) Revenue Growth (1y) (2011 - 2025)
Vivos (RDGL) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.30% |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 | 395.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 395.54% |
| Sep 30, 2025 | -62.42% |
| Jun 30, 2025 | 11.11% |
| Mar 31, 2025 | 494.40% |
| Sep 30, 2024 | -28.57% |
| Jun 30, 2024 | 107.69% |
| Mar 31, 2024 | -25.00% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | -38.10% |
| Mar 31, 2023 | -53.85% |
| Sep 30, 2022 | -56.34% |
| Sep 30, 2021 | 112.67% |
| Sep 30, 2020 | -12.50% |
| Mar 31, 2017 | 0.00% |
| Sep 30, 2016 | -66.37% |
| Mar 31, 2016 | -66.37% |
| Mar 31, 2015 | -14.23% |
| Mar 31, 2014 | -43.34% |
| Sep 30, 2013 | 77.47% |
| Mar 31, 2013 | -63.22% |